All articles tagged with #health equity
At the Seventy-ninth World Health Assembly in Geneva on May 20, 2026, WHO and prize foundations honored six laureates from Mali, Thailand, France, Singapore, Bangladesh and Egypt for strengthening primary health care, expanding access to essential services and reducing inequities, including the Dr LEE Jong-wook Memorial Prize for Public Health; the awards also mark 20 years since Dr Lee Jong-wook’s death.
Africa carries about a quarter of the global disease burden and around 20% of the population, yet its communities are underrepresented in leading randomized trials. An analysis of 2,472 trials from 2019–2024 found only 3.9% conducted exclusively in Africa, with just 0.6% of major cardiovascular trials Africa-only. This underrepresentation undermines external validity and the applicability of results to African populations, while infectious diseases still dominate Africa-based research even as non-communicable diseases rise. The piece argues for Africa-led research, ring-fenced funding, regional trial networks, and better reporting of trial diversity to align global medical knowledge with Africa’s health reality.
PrEP could end HIV in the United States, but access remains uneven due to insurance gaps, provider knowledge gaps, stigma, and racial/geographic disparities; telemedicine and long-acting injections are expanding reach, but affordability and policy changes—like funding cuts to HIV prevention—could threaten progress.
A Cancer Research Communications study finds never-married men have 68% higher cancer rates and never-married women 83% higher than their married counterparts, with the protective effect seemingly accumulating with age. Researchers say marriage may confer health benefits through social support, better healthcare access, and reduced risky behaviors, though some experts caution that findings could reflect broader social systems or biases. The authors advocate more research and increased support for unmarried individuals to ensure equitable care and screening.
A Axios piece argues the body positivity movement remains vital even as a GLP-1–driven slimming trend and celebrity focus dominate media, risking a return to thin-ideal norms. Experts warn this creates a two-tier world where access to medical weight interventions shapes self-perception and mental health, while activists emphasize reframing GLP-1s as disease-treating tools rather than vanity products. The fight for body diversity is framed as a social-justice issue that remains ongoing despite changing trends.
A policy change provides waiting-list credit to Black kidney transplant candidates to offset harms from race-based testing, aiming to reduce disparities and improve access to kidney transplants.
A prospective FDA-funded study called EquiOx measured 631 patients with pulse oximeters against arterial blood gases to quantify bias across skin tones. The preprint results were surprising: they suggested pulse oximeters may underestimate oxygen levels in darker-skinned patients, while also showing higher readings in darker versus lighter skin tones, a combination that undermines a simple universal correction. With the study not yet peer-reviewed, clinicians face unclear guidance on how to adjust readings, and questions remain about study design and applicability. Funding gaps and political pressures around health disparities add to delays in final FDA guidance and larger multi-site research plans, though researchers are pursuing broader datasets and international collaboration (e.g., Uganda) to resolve the issue.
Younger women are increasingly being diagnosed with breast cancer, with rates rising over the past 20 years. Improved screening practices, including earlier mammograms and genetic testing, are crucial for early detection and better outcomes. Health equity initiatives, such as mobile mammogram services, aim to make preventive care more accessible, especially for underserved communities. Understanding individual risk factors and ensuring timely screenings can save lives, as highlighted by the story of Cari Moskow Beegle, a breast cancer survivor diagnosed at 36.
Thea James, vice president of mission and associate chief medical officer at Boston Medical Center, is leading efforts to reduce racial health disparities by prioritizing patient input and empowerment. Through the Health Equity Accelerator initiative, BMC has seen promising results in reducing racial disparities in diabetes risk and postpartum readmissions. By focusing on patient needs and experiences, BMC has implemented simple but effective solutions, such as a blood pressure monitoring strap and standardized protocols, to improve maternal health outcomes and address racial disparities in healthcare.
Thousands of Black kidney transplant candidates have had their wait times modified after a racially biased organ test overestimated their kidney function, delaying their access to transplants. The U.S. organ transplant network ordered hospitals to use race-neutral test results, and more than 14,300 Black kidney transplant candidates have had their wait times adjusted. This is part of a larger effort to address racial bias in medical algorithms and restore faith in the health system, as Black Americans are over three times more likely than white people to experience kidney failure.
Oprah Winfrey's new special, "Shame, Blame, and the Weight Loss Revolution," premiered on ABC and is now available for streaming on Hulu. In the special, Winfrey shares her personal weight loss journey and discusses strategies to release the shame and stigma surrounding weight. The program aims to bring together medical experts and leaders in the space to address health equity and obesity.
Oprah Winfrey is set to host a primetime special on ABC about weight loss drugs following her departure from the board of WeightWatchers, where she revealed her personal use of such medications. Titled “An Oprah Special: Shame, Blame and the Weight Loss Revolution,” the hour-long special will feature medical experts and individuals who have used weight loss medications, aiming to destigmatize and educate viewers on the topic of weight loss. The special will address questions about the intended recipients of these medications, eligibility criteria, and potential side effects. Oprah's decision to step down from the WeightWatchers board came after she publicly disclosed her use of weight loss drugs, emphasizing the importance of recognizing obesity as a chronic condition and advocating for health equity.
The FDA has approved the first over-the-counter continuous glucose monitor, the Dexcom Stelo Glucose Biosensor System, designed for individuals 18 years and older who do not use insulin. This integrated CGM allows users to monitor and analyze glucose levels using a wearable sensor and a smartphone app, providing valuable information about their health without the involvement of a healthcare provider. However, it is not intended for individuals with problematic hypoglycemia. This approval aligns with the FDA's goal of advancing health equity by expanding access to valuable health information for all patients.
Oprah Winfrey is stepping down from the board of directors at WeightWatchers after revealing her use of weight loss medication. She will not seek re-election and plans to donate her earnings from WeightWatchers stock to charity to avoid any conflict of interest. Winfrey aims to continue advocating for health equity and addressing obesity as a chronic condition. Her decision comes after opening up about the shame surrounding weight loss drugs and emphasizing the importance of addressing obesity as a disease.
First-year medical students at UCLA's medical school were reportedly assigned readings advocating for the abolition of borders as a "medical intervention" in a required course on "Structural Racism and Health Equity." The assigned documents included scholarly papers and interviews with activists calling for a "no borders system" and attributing health disparities among migrants to border enforcement, capitalism, war, and climate emergency. A medical transparency group, Do No Harm, criticized the school for promoting "absurd descent into anarchic views of national borders," while the UCLA David Geffen School of Medicine did not immediately respond to requests for comment.